Senti Biosciences is trading 5.12% up at $0.34 in pre-market on October 5, 2026, versus the October 2 close of $0.32, with no clear reason identified.
- Supplied price context indicates a modest rebound from recent closes around $0.31–$0.32.
- No October 5 company announcement explains the move. The latest investor-page release, dated July 15, 2026, concerns a strategic transaction but does not establish a direct reason.
- Broader market indicators are mixed and inconclusive.